New Drug Intesifies Multaq Relsults 9-2010

A new drug, Ranolazine, when used
with Multaq has been found to enhance the effectiveness of AFIB
control. This is news as of 9-27, 2010, according to Gilead lab in
northern California. I urge you to read up on this, it seems to be a major break for us.

REPLY

REPORT

I have obtained a PDF of the recent
paper filed by Masonic Medical Labs based in Utica NY. The animal heart research is very encouraging, when Multaq is administered along with Ranolazine, causing a clear synergy effect. It seems to work
well on the atria, with little effect on the ventricals. Since both are approved for cardiological purposes,
informal testing can perhaps be done using low dosage of the Ranolazine to supplement the effect
in patients with long exposure to Multaq, for AFIB control. Where
cardioconversion has provided a
few weeks of NSR, before relapse
into AFIB, the duration might well be extended, in an informal trial with the Ranolazine added. I for one, having recent sucess with
cardio-version, that lasted nearly 2 weeks, would gladly volunteer to
have the second drug added, and after a loading period try another
cardio-version attempt, so long as the proceedure was closely monitored. I would assume a few
other Multaq patients would likewise volunteer.

REPLY

Was this helpful? 0

Ranolazine is actually not new, it was approved by the FDA to treat Angina Pectoris, back in 2006.

This is just a new use that they are investigating for it. Quite a few medications are known to have a synergistic effect and if this proves out, it will be a great boon for many people.

https:/­/­rxchat.com/­wiki/­Ranolazine/­

https:/­/­rxchat.com/­wiki/­Multaq/­

Does anyone else have any information to add?

REPLY

Was this helpful? 0

Following up on the newly reported
greater effectiveness of the Sanofi
AFIB drug MULTAQ, when used
along with the fairly new Gilead ANGINA drug RANEXA (Ranolazine), in order to control AFIB in dog studies, the effectiveness is projected to be
boosted from 70% in each drug
to about 90% if the patient is
converted into NSR (normal sinus
beat) by another means such as
electro-version. This might avoid
invasive and sometimes danger
proceures such as RF ablation,
or the maze surgery. The doctor
I spoke to pointed out that many
cardiac patients already have an angina issue, from time to time, so
that perscribing the 2 drugs is actually an on label application
for many, many patients, and any
off label use would tend to fall into
the range of closely related symptoms. Close monitoring would,
of course be in order. So, talk to your cardiologist, or electro-physiologist! This might turn your heart problems around, if the new
combintion proves to be very safe!

REPLY

Was this helpful? 0

prescription cost for 30 day supply ## HOW MUCH IS THE COST FOR 30 DAYS TREATMENT? ## @SYLVIA PETRIDOU, Based on my rese...

2 REPLIES

Everyone should research this drug for all the interaction it has with others. My husband was put on it, because he had ...

1 REPLY

Ban Drugs In PUNJAB India IN 2010 And 2011 BY HEALTH MINISTRY ## I'm sorry, but we are based in the U.S. and finding...

5 REPLIES

Does anybody know when the 2010 top 200 drugs list will be out??? I'm trying to study for the PTCB and getting very ...

1 REPLY

Top 200 drugs brand and generic for 2010 ## I cannot give you the list for 2010, because such information is not compile...

5 REPLIES

I have been seeing the same pain management doctor in Ohio for over 12 years for degenerative disc disease with radiculo...

9 REPLIES

I have a question for the FDA and CDC. Drugs like Donnatal which had been on the market before WWII are now considered t...

8 REPLIES

is Simponi better or not than embrel ## I used embrel for six months with no improvement. After a few of taking simponi ...

3 REPLIES

it just came out yr ago if u lose energy doing the work day it gives u a boost ## Hello, Matt! How are you? I'm sorr...

1 REPLY

Hi I am new to this drug starting on 100 mg 3 times a day because I have been getting terrible headaches. I was on ami f...

3 REPLIES